LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Closed

SectorHealthcare

27.01 -2.14

Buy Sell

Overview

Share price change

24h

Current

Min

26.68

Max

27.18

Key metrics
By Trading Economics
Income	-28M 22M
Sales	4.3M 244M
P/E Sector Avg	10.185 57.05
EPS	1.08
Profit margin	9.224
Employees	293
EBITDA	-22M 52M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+49.46% upside

Dividends
By Dow Jones
Next Earnings	5 maj 2026

Market Stats
By TradingEconomics
Market Cap	49M 1.6B
Previous open	29.15
Previous close	27.01

News Sentiment

By Acuity

50%

171 / 350 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

24 mar 2026, 18:58 UTC

Major Market Movers

MDA Space Shares Drop After NASA Shifts Focus to Moon's Surface and Away From Space Station

24 mar 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

24 mar 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

24 mar 2026, 23:33 UTC

Market Talk

Major News Events

Gold Rises, Boosted by Dollar Weakness -- Market Talk

24 mar 2026, 23:16 UTC

Market Talk

Venezuelan Opposition Leader Says Oil Output Could Reach 5 Million B/D -- Market Talk

24 mar 2026, 22:40 UTC

Earnings

Shanghai Fosun Pharmaceutical: Results Supported by Higher Rev From Innovative Drugs, Overseas Business >2196.HK

24 mar 2026, 22:40 UTC

Earnings

Shanghai Fosun Pharmaceutical 2025 Net CNY3.37B Vs. Net CNY2.77B >2196.HK

24 mar 2026, 22:40 UTC

Earnings

Shanghai Fosun Pharmaceutical 2025 Rev CNY41.50B Vs. CNY40.91B >2196.HK

24 mar 2026, 21:44 UTC

Market Talk

Global Equities Roundup: Market Talk

24 mar 2026, 21:44 UTC

Market Talk

Sandfire's New Bull Excited by Kalkaroo Copper Deposit -- Market Talk

24 mar 2026, 20:59 UTC

Earnings

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

24 mar 2026, 20:58 UTC

Major News Events

Israel Hits Russian-Iranian Weapons Smuggling Route in the Caspian Sea -- WSJ

24 mar 2026, 20:50 UTC

Market Talk

Major News Events

Energy & Utilities Roundup: Market Talk

24 mar 2026, 20:50 UTC

Market Talk

Major News Events

Basic Materials Roundup: Market Talk

24 mar 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

24 mar 2026, 20:25 UTC

Earnings

This Palantir-Linked Drone Stock Was Flying Under the Radar -- Until Now -- Barrons.com

24 mar 2026, 20:15 UTC

Market Talk

Major News Events

Global Commodities Roundup: Market Talk

24 mar 2026, 20:10 UTC

Market Talk

Canada Mortgage Arrears Linked to Labor Market Performance -- Market Talk

24 mar 2026, 20:10 UTC

Earnings

Worthington Enterprises 3Q Sales $378.7M >WOR

24 mar 2026, 20:10 UTC

Earnings

Worthington Enterprises 3Q Adj EPS 98c >WOR

24 mar 2026, 20:10 UTC

Earnings

Worthington Enterprises 3Q EPS 92c >WOR

24 mar 2026, 19:25 UTC

Market Talk

Major News Events

Canada Needs Roughly 100 Days to Meet IEA's Oil-Stock Release -- Market Talk

24 mar 2026, 19:06 UTC

Market Talk

Major News Events

Oil Futures Regain Ground As Strikes Continue in Middle East -- Market Talk

24 mar 2026, 18:51 UTC

Market Talk

Major News Events

U.S. Natural Gas Settles Higher As Oil Futures Gain -- Market Talk

24 mar 2026, 18:40 UTC

Market Talk

Major News Events

Global Forex and Fixed Income Roundup: Market Talk

24 mar 2026, 18:40 UTC

Market Talk

Major News Events

Mideast Conflict to Hobble But Not Derail Canadian Economy -- Market Talk

24 mar 2026, 18:34 UTC

Major News Events

Oil Production in the Middle East Will Take Months to Come Back, CEO says. Why $100 Oil Could Be Here to Stay. -- Barrons.com

24 mar 2026, 18:27 UTC

Market Talk

Inflation Pickup Could Keep Bank of Mexico on Hold -- Market Talk

24 mar 2026, 18:21 UTC

Market Talk

Major News Events

Silver Snaps 9-Session Losing Streak -- Market Talk

24 mar 2026, 18:00 UTC

Acquisitions, Mergers, Takeovers

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. -- Barrons.com

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

49.46% upside

12 Months Forecast

Average 41.25 USD 49.46%

High 62 USD

Low 25 USD

Based on 8 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

Buy

Hold

Sell

Based on 8 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

171 / 350 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.